Sabbaticals for Established Scientists

Collaboration and continued learning at all levels of expertise is essential to advancing research.  The Jacki and Bruce Barron Cancer Research Scholars’ Program will offer distinguished mid-career and senior level scientists in Israel a sabbatical of six months at City of Hope. Israel Cancer Research Fund will select these scientists through a competitive process that would be open to researchers across Israel.

Candidates are required to provide recommendations by their institutional leadership, a defined research plan, and identify a collaborator at City of Hope. Scientists in Israel will initiate interactions with City of Hope scientists by reviewing our areas of research. Each scientist would receive funds to cover the costs of travel, housing, lab supplies, conference attendance, and incidental expenses. Scientists will have access to extensive core facilities within the Beckman Research Institute, including three Good Manufacturing Practice facilities for drug development. Israeli scientists will also benefit from City of Hope’s close ties with nearby California Institute of Technology, offering additional opportunities for collaboration and access to pioneering technology.

City of Hope eligible faculty will also have the opportunity to spend a six month sabbatical at an Israeli academic medical center or biomedical research institution. Scientists will receive a stipend of $62,000 to cover the costs of travel, housing, lab supplies, conference attendance and incidental expenses.

 

 

About the Israel Cancer Research Fund

Israel Cancer Research Fund, a 501(c)(3) organization, is the largest nationwide charitable organization in North America solely devoted to supporting cancer research in Israel. Since its establishment in 1975, ICRF has provided more than 2,200 grants to outstanding cancer researchers whose laboratories are located in all of the leading research institutions, universities and hospitals across Israel. For more information, visit www.icrfonline.org.